Activity Description
This activity examines emerging data and techniques in hybrid ablation to optimize AF outcomes, including CONVERGE IDE trial results and application of data into real-world clinical practice, as well as how to address the LAA by combining Convergent ablation with LAA closure. Additionally, as Convergent ablation is a novel hybrid technique that combines endocardial RF ablation and minimally invasive epicardial surgical ablation, the experts will explore the crucial roles of electrophysiologists and surgeons not only in performing the procedure but also as the coordinators and developers of this multidisciplinary service.

• Access Webcast
• Faculty

Access Webcast

 

Access >>

Viewing Options: Click on the presentation titles below to view each individual segment of the activity, or the Access button to view the activity in its entirety (50 Minute Duration).

 

Agenda
		CONVERGE IDE Trial Review: Outcomes and Impact David DeLurgio, MD, FACC, FHRS
		Convergent Procedure with LAA Closure: Addressing the Left Atrial Appendage Felix Yang, MD, FACC, FHRS, CCDS
		The Role of the Surgeons in the Management of Atrial Fibrillation Faraz Kerendi, MD
		Panel Discussion David DeLurgio, MD, FACC, FHRS, Felix Yang, MD, FACC, FHRS, CCDS, Faraz Kerendi, MD

---

Educational grant support provided by AtriCure

Joint Providership
MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Faculty
David DeLurgio, MD, FACC, FHRS Professor of Medicine Division of Cardiology, Department of Medicine Emory University School of Medicine Atlanta, GA		Felix Yang, MD, FACC, FHRS, CCDS Associate Director of Cardiac Electrophysiology Director of the Lead Extraction Service Maimonides Medical Center Brooklyn, NY
Faraz Kerendi, MD Cardiothoracic & Vascular Surgeons, PA Heart Hospital of Austin St. David's Medical Center Austin, TX